Abnova offers monoclonal antibody (mAb) development in mice, rats, and rabbits, with guaranteed success based on standard endpoints or customer's specific applications. Our high rate of success, short turn-around time, and affordable cost are due to our proprietary hybridoma technology, state-of-the-art, specific pathogen-free (SPF) facility, extensive experience in antibody production for over 10,000 gene targets, and flexibility to suit our customer's needs.
Related FAQ | |
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||
|
The above list price is only used for direct orders made to Abnova. |
- oem@abnova.com
- TW : +886-2-8751-1888 / USA : +1(857) 639 0367 / Korea : +82-1670-5911.